FDA Issues Warning Letter to Baxter

Agency claims Deerfield, Ill,-based firm is using misleading device labeling and isn't complying with federal manufacturing standards.

By: Editor

NULL

The U.S. Food and Drug Administration has issued a warning letter to Deerfield, Ill.-based Baxter International Inc., alleging misleading labeling of an unidentified device and noncompliance with federal manufacturing standards.

“Management with executive responsibility failed to ensure that the quality policy is understood, implemented and maintained at all levels of the organization,” said the agency in the warning letter, which was sent to Baxter Sept. 10.

Baxter International wasn’t immediately available for comment.

Go towww.fda.gov/ICECI/EnforcementActions/WarningLetters/ ucm186835.htm to view the complete warning letter.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters